retatrutide parkinson's disease trial nct parkinson Retatrutide Dosing: Early Clinical Trial Insights on How It Might Work Parkinson's research trial numbers remain
Description
As of 2025, retatrutide is in Phase 3 clinical trials and has not been approved by the FDA for any indication
Sig Transduct Target Ther 7 , 298 (2022)
Each meal plan incorporates natural sources clinically proven to alleviate constipation that may occur as a side effect of GLP-1 use
If you have not achieved sufficient or sustained results with these efforts, Zepbound may be an option as part of your personalized care plan
